Collectively, our data underscore the importance of EZH2-mediated SMAD3 K53/K333 methylation in metastasis and indicate that SMAD3 methylation might function as an important factor in predicting overall survival of patients with breast cancer. The gene discussed is EZH2; the disease is breast carcinoma.